Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China · Delayed Price · Currency is CNY 12.25
-0.23 (-1.84%)
Sep 11, 2026, 3:00 PM CST
Shinva Medical Instrument Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,104 | 3,095 | 2,945 | 3,188 | 1,689 | 1,567 |
Short-Term Investments | - | - | - | - | - | 10 |
Trading Asset Securities | - | - | 1.03 | 100.1 | 100.31 | 98.07 |
Cash & Short-Term Investments | 3,104 | 3,095 | 2,946 | 3,288 | 1,789 | 1,675 |
Cash Growth | 2.43% | 5.06% | -10.42% | 83.78% | 6.81% | 20.32% |
Accounts Receivable | 2,692 | 2,311 | 2,306 | 2,110 | 2,004 | 1,772 |
Other Receivables | 346.71 | 327.47 | 461.42 | 238.49 | 235.97 | 181.24 |
Receivables | 3,039 | 2,638 | 2,768 | 2,348 | 2,240 | 1,953 |
Inventory | 2,644 | 2,903 | 3,356 | 3,556 | 3,029 | 2,306 |
Prepaid Expenses | - | 0.66 | 2.02 | 0.18 | 0.07 | 0.01 |
Other Current Assets | 320.83 | 256.38 | 294.27 | 261.95 | 327.01 | 243.2 |
Total Current Assets | 9,108 | 8,894 | 9,366 | 9,454 | 7,385 | 6,177 |
Property, Plant & Equipment | 3,222 | 3,269 | 3,181 | 3,013 | 2,526 | 2,396 |
Long-Term Investments | 1,324 | 1,367 | 1,640 | 1,787 | 1,712 | 1,684 |
Goodwill | 242.04 | 242.04 | 242.04 | 257.26 | 268.76 | 268.76 |
Other Intangible Assets | 439.73 | 447.2 | 469.87 | 478.06 | 478.53 | 461.25 |
Long-Term Accounts Receivable | - | 12.93 | 9.38 | 14.78 | 1.37 | 28.92 |
Long-Term Deferred Tax Assets | 128.68 | 129.35 | 122.45 | 115.96 | 90.34 | 69.66 |
Long-Term Deferred Charges | 123.85 | 123.54 | 123.24 | 123.33 | 132.28 | 148.63 |
Other Long-Term Assets | 356.13 | 334.31 | 373.08 | 346.4 | 366.56 | 378.67 |
Total Assets | 14,944 | 14,820 | 15,526 | 15,590 | 12,961 | 11,614 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2,794 | 2,532 | 2,754 | 2,443 | 2,497 | 2,193 |
Accrued Expenses | 228.34 | 480.99 | 440.29 | 508.64 | 450.4 | 333.52 |
Short-Term Debt | 835.44 | 925.14 | 900.61 | 871.95 | 986.4 | 926.39 |
Current Portion of Long-Term Debt | 63.66 | 102.12 | 107 | 28.47 | 59.23 | 94.32 |
Current Portion of Leases | - | 18.24 | 17.98 | 22.82 | 21.39 | 17.34 |
Current Income Taxes Payable | 147.54 | 13.03 | 39.37 | 31.96 | 32.63 | 67.47 |
Current Unearned Revenue | 1,418 | 1,649 | 2,049 | 2,336 | 2,042 | 1,761 |
Other Current Liabilities | 909.54 | 826.95 | 928.1 | 1,254 | 817.42 | 627.9 |
Total Current Liabilities | 6,396 | 6,547 | 7,237 | 7,498 | 6,906 | 6,021 |
Long-Term Debt | 131.47 | 90.57 | 80.48 | 137.8 | 96.33 | 58.66 |
Long-Term Leases | 47.48 | 50.55 | 29.83 | 37.95 | 29.37 | 89.77 |
Long-Term Unearned Revenue | 82.61 | 77.92 | 78.76 | 61.67 | 52.62 | 53.69 |
Long-Term Deferred Tax Liabilities | 98.14 | 95.85 | 94.87 | 96.04 | 82.75 | 116.04 |
Other Long-Term Liabilities | 1.05 | - | 22.77 | 39.44 | 6.4 | 6.4 |
Total Liabilities | 6,757 | 6,862 | 7,544 | 7,870 | 7,174 | 6,345 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 606.64 | 606.68 | 606.68 | 466.68 | 411.97 | 406.43 |
Additional Paid-In Capital | 2,490 | 2,497 | 2,716 | 3,000 | 1,723 | 1,667 |
Retained Earnings | 4,788 | 4,563 | 4,324 | 3,867 | 3,283 | 2,838 |
Treasury Stock | - | -17.74 | -37.8 | -60.28 | -62.46 | - |
Comprehensive Income & Other | -19.22 | -15.35 | -11.41 | 45.08 | 35.49 | 3.48 |
Total Common Equity | 7,865 | 7,634 | 7,597 | 7,319 | 5,391 | 4,915 |
Minority Interest | 322.25 | 323.15 | 385.5 | 401.21 | 396.27 | 353.72 |
Shareholders' Equity | 8,187 | 7,957 | 7,983 | 7,720 | 5,787 | 5,268 |
Total Liabilities & Equity | 14,944 | 14,820 | 15,526 | 15,590 | 12,961 | 11,614 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,078 | 1,187 | 1,136 | 1,099 | 1,193 | 1,186 |
Net Cash (Debt) | 2,026 | 1,908 | 1,810 | 2,189 | 596.64 | 488.82 |
Net Cash Growth | 8.26% | 5.44% | -17.34% | 266.96% | 22.06% | - |
Net Cash Per Share | 3.34 | 3.15 | 2.98 | 3.65 | 1.13 | 0.93 |
Filing Date Shares Outstanding | 593.66 | 606.68 | 606.68 | 606.69 | 606.94 | 535.57 |
Total Common Shares Outstanding | 593.66 | 606.68 | 606.68 | 606.69 | 535.57 | 528.36 |
Working Capital | 2,711 | 2,346 | 2,129 | 1,957 | 478.72 | 156.3 |
Book Value Per Share | 13.25 | 12.58 | 12.52 | 12.06 | 10.07 | 9.30 |
Tangible Book Value | 7,183 | 6,945 | 6,885 | 6,583 | 4,644 | 4,185 |
Tangible Book Value Per Share | 12.10 | 11.45 | 11.35 | 10.85 | 8.67 | 7.92 |
Buildings | - | 3,225 | 2,711 | 2,148 | 2,114 | 2,071 |
Machinery | - | 1,415 | 1,357 | 1,351 | 1,212 | 1,117 |
Construction In Progress | - | 21.07 | 466.9 | 739.97 | 304.46 | 122.97 |